10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,794 | -30.9% | 1,595 | -6.5% | 0.00% | -100.0% |
| Q2 2023 | $95,263 | +29.0% | 1,706 | +28.9% | 0.00% | – |
| Q1 2023 | $73,866 | +48.9% | 1,324 | -2.7% | 0.00% | – |
| Q4 2022 | $49,595 | +24.0% | 1,361 | -2.2% | 0.00% | – |
| Q3 2022 | $40,000 | -35.5% | 1,392 | +1.5% | 0.00% | – |
| Q2 2022 | $62,000 | -49.2% | 1,371 | -14.6% | 0.00% | -100.0% |
| Q1 2022 | $122,000 | -49.0% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $239,000 | 0.0% | 1,605 | -2.3% | 0.00% | 0.0% |
| Q3 2021 | $239,000 | -30.9% | 1,643 | -7.0% | 0.00% | 0.0% |
| Q2 2021 | $346,000 | +48.5% | 1,767 | +37.2% | 0.00% | 0.0% |
| Q1 2021 | $233,000 | +14.2% | 1,288 | -10.7% | 0.00% | 0.0% |
| Q4 2020 | $204,000 | +9.1% | 1,442 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $187,000 | +40.6% | 1,502 | +0.9% | 0.00% | 0.0% |
| Q2 2020 | $133,000 | – | 1,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |